Progression of COVID-19 in a Patient on Anti-CD20 Antibody Treatment: Case Report and Literature Review

Accumulating evidence suggests that anti-CD20 treatments are associated with a more severe course of COVID-19. We present the case of a 72-year-old woman treated with the B-cell-depleting anti-CD20 antibody rituximab for seropositive rheumatoid arthritis with severe acute respiratory syndrome corona...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgener, Sebastian, Rochat, Philippe, Dollenmaier, Günter, Benz, Gabriel, Kistler, Andreas D., Fulchini, Rosamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896938/
https://www.ncbi.nlm.nih.gov/pubmed/35251723
http://dx.doi.org/10.1155/2022/8712424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896938/
https://www.ncbi.nlm.nih.gov/pubmed/35251723
http://dx.doi.org/10.1155/2022/8712424

Ejemplares similares